02 Feb. 2010
WILMINGTON, N.C. (February 2, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it is celebrating 25 years as one of the world's leading contract research organizations, building upon its strong foundation and history of helping clients deliver safe, effective medicines to patients.
Founded in 1985 as a one-person consulting firm by Fred Eshelman, PPD went public in early 1996. Over the past 25 years, PPD has strengthened its services, technologies and geographic reach through acquisitions and organic growth to meet growing client demand. Today, PPD employs more than 10,500 professionals with 85 offices, clinics and labs in 40 countries. It delivers a full range of discovery, development and laboratory services to biopharmaceutical and medical device companies and academic and government organizations across the globe.
"From day one, our commitment at PPD has been to deliver exceptional service, consistent quality and innovative ideas that help our clients and partners achieve their research and development goals," said Eshelman, executive chairman of PPD. "We take pride in what we have achieved in our first quarter century and salute our employees who consistently bring expertise, dedication and a passion for doing what's right for our clients, patients and sites."
With its solid financial performance, broad global reach and strong client focus, PPD is well-positioned to continue to address challenges facing biopharmaceutical companies. The rising cost of drug development, globalization in clinical research and increased scrutiny by regulatory agencies such as the Food and Drug Administration are areas where PPD is pursuing new approaches, innovative alliances and unique partnering opportunities to face these challenges.
"PPD has a strong history and legacy of assisting our clients with their drug discovery and development needs," said David Grange, chief executive officer, PPD. "As we enter into 2010, we will continue to build on this 25-year heritage and develop innovative solutions for our clients as they deliver life-changing medicines to patients."